Alzheimer's disease is one of the most significant neurodegenerative diseases, affecting millions of people worldwide and characterized by progressive cognitive decline. The fact that a definitive cure for the disease has not yet been found is driving researchers to conduct studies aimed not only at alleviating symptoms but also at understanding how the disease spreads within the brain. In this context, a new study conducted by researchers at University of Utah Health and published in the journal Cell has revealed findings that could mark a significant turning point in Alzheimer’s research.
The research team demonstrated that a protein called Arc (Activity-Regulated Cytoskeleton-associated Protein)— which normally plays a role in communication between nerve cells—facilitates the transport of toxic Tau proteins to healthy neurons in Alzheimer’s disease. The identification of this mechanism offers a new biological model that could explain why the disease spreads to different regions of the brain over time.
The Unexpected Relationship Between the Arc Protein and Tau Proteins
One of the fundamental biological characteristics of Alzheimer’s disease is that Tau proteins lose their normal structure, clump together, and form toxic tangles within nerve cells. These aggregates disrupt the neurons’ intracellular transport systems, eventually leading to cell death. However, for many years, researchers have been unable to fully explain how these toxic Tau proteins enter healthy brain cells.
In the mouse models used in the study, researchers determined that the Arc protein transports Tau proteins within microscopic membrane structures called extracellular vesicles (EVs). While these vesicles are normally used to transport information and molecules between cells, in Alzheimer’s disease, the same system facilitates the spread of the disease.
The study’s first author, Dr. Mitali Tyagi, describes Tau proteins as “sticky monsters.” According to the study, these proteins can break down into small fragments and migrate to other neurons, where they disrupt healthy Tau proteins upon arrival, triggering a chain reaction that leads to the formation of new protein clusters. As a result, the disease spreads to increasingly larger areas of the brain.
Researchers Point to a New Treatment Approach
One of the study’s most striking findings was that when the Arc protein was eliminated, the transport of Tau between cells came to a near-complete halt. This result indicates that Arc plays a critical role in the progression of Alzheimer’s disease.
However, the researchers also emphasize that Arc is not entirely a harmful protein. This is because Arc also helps expel excess Tau proteins from diseased neurons. In the absence of Arc, toxic Tau can accumulate within the cell, leading to the faster death of already damaged neurons.
For this reason, scientists believe that future treatments should aim to block the entry of extracellular vesicles containing Arc and Tau into healthy neurons, rather than completely suppressing the Arc protein—a strategy that could be a safer and more effective approach. Such a strategy could slow the rate at which the disease spreads within the brain.
How Might This Discovery Impact Alzheimer’s Treatment?
Researchers also detected extracellular vesicles carrying both Arc and Tau proteins in human brain tissue. This suggests that the mechanism observed in mice may also exist in humans. However, scientists emphasize that this mechanism must be thoroughly validated in humans before moving to clinical applications.
The study’s senior author, Prof. Jason Shepherd, states that while the current findings do not directly translate into a new treatment, they do offer an entirely new target for Alzheimer’s research. If the delivery of Tau-carrying vesicles to healthy cells can be blocked, the progression of the disease could be slowed, and cognitive decline could be kept under control for a longer period.
In recent years, research on Alzheimer’s disease has begun to focus not only on amyloid plaques but also on Tau biology and intercellular communication mechanisms. This study by researchers at the University of Utah Health establishes an important scientific foundation for the development of next-generation treatment strategies aimed at halting the progression of the disease, while also providing a promising roadmap for future clinical trials.
